• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Suez Canal University Medical Journal
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 28 (2025)
Volume Volume 27 (2024)
Issue Issue 12
Issue Issue 11
Issue Issue 10
Issue Issue 9
Issue Issue 8
Issue Issue 7
Issue Issue 6
Issue Issue 5
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 26 (2023)
Volume Volume 25 (2022)
Volume Volume 24 (2021)
Volume Volume 23 (2020)
Volume Volume 22 (2019)
Volume Volume 21 (2018)
Volume Volume 20 (2017)
Volume Volume 19 (2016)
Volume Volume 18 (2015)
Volume Volume 17 (2014)
Volume Volume 16 (2013)
Volume Volume 15 (2012)
Volume Volume 14 (2011)
Volume Volume 13 (2010)
Aboelroos, S., Eltamany, E., Mohamed, F., Suliman, M. (2024). Evaluation of PvuII (rs2234693) and AhR (rs2066853) Gene Polymorphisms‎ ‎as Prognostic Markers in Breast Cancer. Suez Canal University Medical Journal, 27(6), 24-34. doi: 10.21608/scumj.2024.421503
Sara Abd EL-Monem Aboelroos; Elsayed Hussein Mostafa Eltamany; Faten Abdelmonem Metwalli Mohamed; Marwa Awad Suliman. "Evaluation of PvuII (rs2234693) and AhR (rs2066853) Gene Polymorphisms‎ ‎as Prognostic Markers in Breast Cancer". Suez Canal University Medical Journal, 27, 6, 2024, 24-34. doi: 10.21608/scumj.2024.421503
Aboelroos, S., Eltamany, E., Mohamed, F., Suliman, M. (2024). 'Evaluation of PvuII (rs2234693) and AhR (rs2066853) Gene Polymorphisms‎ ‎as Prognostic Markers in Breast Cancer', Suez Canal University Medical Journal, 27(6), pp. 24-34. doi: 10.21608/scumj.2024.421503
Aboelroos, S., Eltamany, E., Mohamed, F., Suliman, M. Evaluation of PvuII (rs2234693) and AhR (rs2066853) Gene Polymorphisms‎ ‎as Prognostic Markers in Breast Cancer. Suez Canal University Medical Journal, 2024; 27(6): 24-34. doi: 10.21608/scumj.2024.421503

Evaluation of PvuII (rs2234693) and AhR (rs2066853) Gene Polymorphisms‎ ‎as Prognostic Markers in Breast Cancer

Article 3, Volume 27, Issue 6, June 2024, Page 24-34  XML PDF (581.74 K)
Document Type: Original Article
DOI: 10.21608/scumj.2024.421503
View on SCiNiTO View on SCiNiTO
Authors
Sara Abd EL-Monem Aboelroosorcid 1; Elsayed Hussein Mostafa Eltamanyorcid 2; Faten Abdelmonem Metwalli Mohamed email orcid 3; Marwa Awad Sulimanorcid 4
1Department of Clinical Pathology, Faculty of Medicine, Suez Canal University, Egypt.
2Department of Organic Chemistry, Faculty of Science, Suez Canal University, Egypt.
3Department of Biochemistry, Faculty of Science, Suez Canal University, Egypt.
4Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Suez Canal University, Egypt.
Abstract
Background: the most common cancer detected in females is ‎breast ‎cancer. Several genetic alterations may have prognostic effect on ‎breast ‎cancer. Single-nucleotide polymorphisms might predict breast ‎cancer ‎management. Single nucleotide polymorphisms of PvuII ‎‎(T/C ‎substitution) and aryl hydrocarbon (G/A substitution) were ‎estimated as ‎probable genetic prognostic factors for breast cancer. Aim: ‎to assess the ‎relation between estrogen receptor alpha PvuII (rs2234693) ‎and aryl ‎hydrocarbon receptor gene polymorphisms (rs2066853) in ‎breast cancer ‎prognosis. Material and method: this study is case-control ‎that ‎enrolled 120 breast cancer patients categorized into two groups: the ‎first ‎one involved 60 females with good prognostic factors, the second ‎group ‎included 60 females with poor prognostic factors. Genotyping ‎assay ‎were done by a real-time polymerase chain reaction. Results: our ‎finding ‎revealed that the allelic frequency of wild-type genotypes for ‎PvuII and ‎AhR polymorphisms was associated with patients who had ‎better ‎prognosis for breast cancer. Their mutant genotypes were ‎significantly ‎associated with poor prognoses in breast cancer patients. ‎Conclusion: ‎PvuII, AhR genotypes were statistically significant ‎associated with ‎breast cancer ‎ prognosis. ‎
Keywords
Genetic factors; Estrogen receptor; aryl hydrocarbon; prognosis
Main Subjects
Clinical Research (Medical)
Statistics
Article View: 87
PDF Download: 85
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.